Institute of Biomedical Research Corp. (MRES)
OTCMKTS · Delayed Price · Currency is USD
0.0011
+0.00009 (8.91%)
At close: Mar 27, 2026
MRES Market Cap
MRES has a market cap or net worth of $3.02 million as of March 27, 2026. Its market cap has decreased by -91.91% in one year.
Market Cap
3.02M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since March 31, 2016, MRES's market cap has increased from 693.95K to 3.02M, an increase of 335.80%. That is a compound annual growth rate of 15.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 3.02M | -60.71% |
| Dec 31, 2025 | 7.70M | -83.96% |
| Dec 31, 2024 | 47.98M | 138.03% |
| Dec 29, 2023 | 20.16M | 17.54% |
| Dec 30, 2022 | 17.15M | 149.69% |
| Dec 31, 2021 | 6.87M | 971.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GPL Holdings | 4.17M |
| Galera Therapeutics | 3.32M |
| Vaccinex | 3.19M |
| Oncology Pharma | 2.94M |
| Clearside Biomedical | 2.83M |
| Burzynski Research Institute | 2.67M |
| VitaSpring Biomedical | 2.30M |
| CASI Pharmaceuticals | 2.26M |